Inhibition of GBP1 alleviates pyroptosis of human pulmonary microvascular endothelial cells through STAT1/NLRP3/GSDMD pathway
Molecular Immunology · 2024
DOI: 10.1016/j.molimm.2024.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2024. Verfasst von Yingting Hao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: …. Hauptthemen laut MEDLINE: Endothelial Cells, GTP-Binding Proteins, Lung, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Restoring and maintaining the function of endothelial cells is critical for acute respiratory distress syndrome (ARDS). Guanylate binding protein 1(GBP1) is proved to elevated in ARDS patients, but its role and mechanism remains unclear. The objective of this study is to investigate the internal mechanism of GBP1 in lung injury. Our study showed that when the LPS and IFN-γ induced human Pulmonary Microvascular Endothelial Cells (HPMECs) injury model was established, cell viability was significantly reduced, and the levels of GBP1 levels and inflammatory factors were significantly increased. When transfection with si-GBP1, low expression of GBP1 promoted cell proliferation and migration, and decreased the expression of downstream inflammatory factors. Furthermore, the inhibition of GBP1 significantly reduced the occurrence of cell pyroptosis and the expression of NLRP3 and STAT1. Our study indicated that GBP1 alleviates endothelial pyroptosis and inflammation through STAT1 / NLRP3/GSDMD signaling pathway, and GBP1 may be a new target in the treatment of lung injury in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: haoyingting256@163.com.
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: fuhongxue1995@163.com.
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: 2019110257@stu.cqmu.edu.cn.
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: zouxuan101@foxmail.com.
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: zhouxin11300306@163.com.
- Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: ttxy111@126.com.
Zitieren
APA
Hao, Y., Fu, H., Li, K., Zou, X., Zhou, X., Tang, X., Liu, C., & Zhou, F. (2024). Inhibition of GBP1 alleviates pyroptosis of human pulmonary microvascular endothelial cells through STAT1/NLRP3/GSDMD pathway. Molecular Immunology. https://doi.org/10.1016/j.molimm.2024.07.005
Vancouver
Hao Y, Fu H, Li K, Zou X, Zhou X, Tang X, et al. Inhibition of GBP1 alleviates pyroptosis of human pulmonary microvascular endothelial cells through STAT1/NLRP3/GSDMD pathway. Molecular Immunology. 2024. doi:10.1016/j.molimm.2024.07.005
BibTeX
@article{Hao2024,
author = {Hao, Yingting and Fu, Hongxue and Li, Kaili and Zou, Xuan and Zhou, Xin and Tang, Xiyue and Liu, Chang and Zhou, Fachun},
title = {Inhibition of GBP1 alleviates pyroptosis of human pulmonary microvascular endothelial cells through STAT1/NLRP3/GSDMD pathway},
journal = {Molecular Immunology},
year = {2024},
doi = {10.1016/j.molimm.2024.07.005}
}
EUVIMED